Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
51.27
-1.20 (-2.29%)
At close: Aug 6, 2026, 4:00 PM EDT
51.27
0.00 (0.00%)
After-hours: Aug 6, 2026, 4:04 PM EDT
Bruker Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 184.9 | 298.8 | 183.4 | 488.3 | 645.5 | 1,068 |
Short-Term Investments | - | - | - | - | - | 100 |
Cash & Short-Term Investments | 184.9 | 298.8 | 183.4 | 488.3 | 645.5 | 1,068 |
Cash Growth | 100.98% | 62.92% | -62.44% | -24.35% | -39.57% | 56.67% |
Accounts Receivable | 545.9 | 544.9 | 565.5 | 492 | 472.7 | 416.9 |
Inventory | 1,120 | 1,095 | 1,068 | 968.3 | 800.1 | 710.1 |
Other Current Assets | 374.1 | 274.2 | 236.5 | 215.6 | 194.9 | 176.6 |
Total Current Assets | 2,225 | 2,213 | 2,053 | 2,164 | 2,113 | 2,472 |
Net Property, Plant & Equipment | 714.1 | 910.6 | 814.8 | 691.4 | 538.2 | 466 |
Other Intangible Assets | - | 899.6 | 912.5 | 330.5 | 270.9 | 211.8 |
Goodwill | 2,298 | 1,548 | 1,507 | 582.6 | 457.6 | 339.5 |
Other Long-Term Assets | 816.2 | 671 | 518.9 | 481.2 | 231.9 | 160.9 |
Total Assets | 6,053 | 6,241 | 5,807 | 4,250 | 3,612 | 3,650 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 200.2 | 215.9 | 234.1 | 202.7 | 178.4 | 147.4 |
Current Portion of Long-Term Debt | 10.1 | 16.6 | 32.5 | 121.2 | 18.7 | 112.4 |
Unearned Revenue | 444.6 | 441.3 | 438.2 | 400 | 370.2 | 197.5 |
Other Current Liabilities | 549.8 | 605.4 | 576.5 | 478.2 | 347 | 481.2 |
Total Current Liabilities | 1,205 | 1,279 | 1,281 | 1,202 | 914.3 | 938.5 |
Long-Term Debt | 1,815 | 1,853 | 2,062 | 1,160 | 1,201 | 1,222 |
Long-Term Leases | - | 138.6 | 118.9 | 74.8 | 34.8 | 41.8 |
Other Long-Term Liabilities | 597.7 | 460.8 | 529.5 | 399.4 | 330.4 | 363.1 |
Total Long-Term Liabilities | 2,412 | 2,452 | 2,710 | 1,635 | 1,566 | 1,627 |
Total Liabilities | 3,617 | 3,731 | 3,992 | 2,837 | 2,480 | 2,565 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 |
Treasury Stock | - | -1,242 | -1,237 | -1,237 | -1,085 | -820.3 |
Additional Paid-in Capital | - | 1,415 | 713.4 | 282.9 | 256.3 | 237.8 |
Accumulated Other Comprehensive Income | - | -79.5 | -103.5 | 6 | 14.8 | -8.2 |
Retained Earnings | - | 2,362 | 2,407 | 2,324 | 1,926 | 1,660 |
Total Common Shareholders' Equity | - | 2,457 | 1,781 | 1,377 | 1,114 | 1,071 |
Minority Interest | 35.6 | 53.8 | 34 | 36.1 | 18 | 14.3 |
Shareholders' Equity | 35.6 | 2,510 | 1,815 | 1,413 | 1,132 | 1,085 |
Total Liabilities & Equity | 6,053 | 6,241 | 5,807 | 4,250 | 3,612 | 3,650 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,825 | 2,008 | 2,213 | 1,356 | 1,254 | 1,376 |
Net Cash (Debt) | -1,640 | -1,709 | -2,030 | -868 | -608.5 | -307.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -10.77 | -11.26 | -13.58 | -5.90 | -4.07 | -2.01 |
Book Value | - | 2,457 | 1,781 | 1,377 | 1,114 | 1,071 |
Book Value Per Share | - | 16.18 | 11.91 | 9.36 | 7.46 | 7.00 |
Tangible Book Value | -2,298 | 9.2 | -638.6 | 464.1 | 385.3 | 519.2 |
Tangible Book Value Per Share | -15.08 | 0.06 | -4.27 | 3.15 | 2.58 | 3.40 |